Back to Search
Start Over
Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2V617F-Induced Murine MPD Model.
- Source :
- Blood; November 2009, Vol. 114 Issue: 22 p3897-3897, 1p
- Publication Year :
- 2009
-
Abstract
- Markovtsov: Rigel Pharmaceuticals,Inc.: Employment. Bhamidipati:Rigel Pharmaceuticals,Inc.: Employment. Park:Rigel Pharmaceuticals,Inc.: Employment. Torneros:Rigel Pharmaceuticals,Inc.: Employment. Duan:Rigel Pharmaceuticals,Inc.: Employment. Hitoshi:Rigel Pharmaceuticals,Inc.: Employment. Shimoda:Rigel Pharmaceuticals,Inc.: Research Funding.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 114
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs52991497
- Full Text :
- https://doi.org/10.1182/blood.V114.22.3897.3897